<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00823095</url>
  </required_header>
  <id_info>
    <org_study_id>TNO-1B</org_study_id>
    <secondary_id>DMF 15551</secondary_id>
    <secondary_id>IND 68617</secondary_id>
    <nct_id>NCT00823095</nct_id>
  </id_info>
  <brief_title>Topical Nitric Oxide Trial in Chronic Non-Healing Wounds</brief_title>
  <official_title>The Observational Effects of the Topical Application of ViaNOx-H (Gaseous Nitric Oxide) on the Bio-Burden in Chronic Non-Healing Colonized Ulcers of the Lower Extremities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nitric BioTherapeutics, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the effects of topically applied ViaNOx-H for 8 hours daily for 2 weeks on the
      reduction of the bio-burden in biofilms on chronic non-healing wounds as recorded by
      measurements of wound size and wound culture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary goal of this study is to determine the effects of topically applied gaseous
      nitric oxide on the bio-burden of chronic non-healing wounds of the lower extremities.
      Reports will include:

        -  Comparisons of the demographics and diagnoses of those patients treated with ViaNOx-H.

        -  Tabulation as to the organisms found and the bio-burden as measured by counts (0 to +4).

        -  Tabulation of the number and types of adverse events during ViaNOx-H treatment.

        -  Comparisons of the response of different organisms to ViaNOx-H treatment.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Subject recuitment halted and won't resume; subjects are no longer being treated.
  </why_stopped>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Primary Endpoint is the Eradication of the Bio-burden as Measured by a Reduction in Culture Growth to ≤ +2.</measure>
    <time_frame>at 28 days post enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Secondary Endpoint Measure is a Reduction on Wound Size.</measure>
    <time_frame>28 days post enrollment</time_frame>
    <description>reduction in bioburden as assessed by number of cfu's per cm2 on culture</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Chronic Ulcer of Lower Extremity</condition>
  <arm_group>
    <arm_group_label>Topically applied Nitric Oxide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Topically applied Nitric Oxide for 8 hours daily for 2 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitric Oxide</intervention_name>
    <description>Topically applied gaseous nitric oxide at 8 to 10 parts per million, for 8 hours each night for 14 nights.</description>
    <arm_group_label>Topically applied Nitric Oxide</arm_group_label>
    <other_name>ViaNOx-H</other_name>
    <other_name>gaseous nitric oxide</other_name>
    <other_name>gNO</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have a chronic (&gt; 8 weeks duration) colonized cutaneous ulcer (defined as a wound
             containing a local margin of erythema, edema or tenderness; presence of exudates;
             and/or presence of a malodorous smell)in their lower extremity (below the knee)
             resulting from either diabetes or venous stasis disease.

          -  Are 18 years of age or older.

        Exclusion Criteria:

          -  Have had a change in their topical treatment during the last 4 weeks

          -  Have evidence of Clinical Infection

          -  Have a transcutaneous oxygen tension &lt;30mmHg

          -  Have evidence of the ulcer or infection extending to the underlying muscle or bone.

          -  Are pregnant.

          -  Are less than 18 years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Takkin Lo, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loma Linda University Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2009</study_first_submitted>
  <study_first_submitted_qc>January 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2009</study_first_posted>
  <results_first_submitted>August 2, 2013</results_first_submitted>
  <results_first_submitted_qc>April 2, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 5, 2014</results_first_posted>
  <last_update_submitted>January 28, 2016</last_update_submitted>
  <last_update_submitted_qc>January 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic cutaneous ulcers</keyword>
  <keyword>Nitric Oxide</keyword>
  <keyword>topically applied</keyword>
  <keyword>Biofilm</keyword>
  <keyword>Colonized chronic non-healing ulcers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Skin Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Topically Applied Nitric Oxide</title>
          <description>Topically applied gaseous nitric oxide at 8 to 10 parts per million, for 8 hours each night for 14 nights.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group 1</title>
          <description>Treatment</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Evidence of a colonized wound on the lower extremity.</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 to 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Primary Endpoint is the Eradication of the Bio-burden as Measured by a Reduction in Culture Growth to ≤ +2.</title>
        <time_frame>at 28 days post enrollment</time_frame>
        <population>Data not available for this study due to dissolution of company contracted to perform study analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Treatment</description>
          </group>
        </group_list>
        <measure>
          <title>The Primary Endpoint is the Eradication of the Bio-burden as Measured by a Reduction in Culture Growth to ≤ +2.</title>
          <population>Data not available for this study due to dissolution of company contracted to perform study analysis</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Secondary Endpoint Measure is a Reduction on Wound Size.</title>
        <description>reduction in bioburden as assessed by number of cfu's per cm2 on culture</description>
        <time_frame>28 days post enrollment</time_frame>
        <population>Data not available for this study due to dissolution of company contracted to perform analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>reduction in bioburden as assessed by number of cfu's per cm2 on culture</description>
          </group>
        </group_list>
        <measure>
          <title>The Secondary Endpoint Measure is a Reduction on Wound Size.</title>
          <description>reduction in bioburden as assessed by number of cfu's per cm2 on culture</description>
          <population>Data not available for this study due to dissolution of company contracted to perform analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Group 1</title>
          <description>Treatment</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No data available for this study due to dissolution of company contracted to perform study analysis.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Deborah Dodge</name_or_title>
      <organization>Loma Linda University Medical Center</organization>
      <phone>(909) 558-4000 ext 48500</phone>
      <email>ddodge@llu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

